USANA Health Sciences, Inc. (USNA)
Price:
21.08 USD
( - -0.18 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Hormel Foods Corporation
VALUE SCORE:
6
2nd position
General Mills, Inc.
VALUE SCORE:
10
The best
Nomad Foods Limited
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
DESCRIPTION
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
NEWS

Protein Pop Launches Protein Pop Plus at Costco Nationwide
prnewswire.com
2026-02-25 07:07:00The brand expands its Protein Pop line with a carbonated, clear protein beverage delivering 30 grams of protein per can SALT LAKE CITY, Feb. 25, 2026 /PRNewswire/ -- Rise Wellness announced the expansion of its Protein Pop offering with the launch of Protein Pop Plus, a new carbonated, ready‑to‑drink clear protein beverage now available at all 607 Costco locations across the United States. Protein Pop Plus builds on the success of the brand's original Protein Pop line, offering consumers a bold new way to enjoy high‑protein nutrition in a refreshing, carbonated format.

Joshua Foukas Sells 4,461 Shares of USANA Health Sciences (NYSE:USNA) Stock
defenseworld.net
2026-02-25 04:44:53USANA Health Sciences, Inc. (NYSE: USNA - Get Free Report) insider Joshua Foukas sold 4,461 shares of the business's stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $21.34, for a total transaction of $95,197.74. The transaction was disclosed in a filing with the Securities and

USNA or UTHR: Which Is the Better Value Stock Right Now?
zacks.com
2026-02-23 12:41:11Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors?

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-18 12:55:13USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
zacks.com
2026-02-17 18:25:28USANA Health Sciences (USNA) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.64 per share a year ago.

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook
businesswire.com
2026-02-17 16:15:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results Q4 2025 Q4 2024 FY 2025 FY 2024 Net sales $226.2 $213.6 $925.3 $854.5 Net (loss) earnings* $-1.8 $4.5 $10.8 $42.0 Diluted EPS $-0.10 $0.23 $0.58 $2.19 Adjusted diluted EPS(1) $0.60 $0.64 $1.93 $2.59 Adjusted EBITDA(2) $27.3 $25.5 $101.3 $110.3 USAN.

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
zacks.com
2026-02-10 11:00:59USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

USANA Exec. Chairman/CEO Kevin Guest on Self-Renewal Day: Break Comfort Zones for Strategic Growth with Six Steps
prnewswire.com
2026-02-02 07:05:00SALT LAKE CITY, Feb. 2, 2026 /PRNewswire/ -- As organizations face rapid market disruption and evolving leadership demands, Feb. 2 marks Self-Renewal Day, a pivotal time for business leaders to recalibrate strategies and personal development. "Growth does not happen by accident; it happens by choice," said Kevin Guest, Executive Chairman & CEO at USANA Health Sciences (NYSE: USNA).

The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
prnewswire.com
2026-01-19 12:10:00/PRNewswire/ -- The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes

Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS)
feeds.newsfilecorp.com
2026-01-14 16:41:00Dallas, Texas--(Newsfile Corp. - January 14, 2026) - Stonegate Capital Partners attended the 2026

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
businesswire.com
2026-01-12 06:15:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA's strategy, including the Company's initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 cons.

Kevin Guest Returns to USANA Health Sciences as CEO
businesswire.com
2026-01-08 09:00:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and wi.

USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset
prnewswire.com
2026-01-05 07:13:00SALT LAKE CITY, Jan. 5, 2026 /PRNewswire/ -- As leaders everywhere set sights on the new year, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA), is encouraging professionals to embrace a growth mindset as the key to lasting achievement and fulfillment. "Success is about the experiences you have, the relationships you build, and the lessons you apply," said Guest, who is also the author of the bestseller, All the Right Reasons: 12 Principles for Living a Life in Harmony.

USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families
prnewswire.com
2025-12-23 06:52:00More than 5,100 food bags delivered to help support children during winter break SALT LAKE CITY , Dec. 23, 2025 /PRNewswire/ -- The holiday season is meant to be a time of celebration, yet for many children who depend on school meals, extended breaks can bring uncertainty. To help bridge that gap, the USANA Foundation - through its Utah-focused Kids Eat program - once again mobilized its annual holiday food pack initiative to help ensure families across Utah had access to nutritious meals while school was out of session.

Analyzing NLS Pharmaceutics (NASDAQ:NCEL) & USANA Health Sciences (NYSE:USNA)
defenseworld.net
2025-12-19 02:00:48USANA Health Sciences (NYSE: USNA - Get Free Report) and NLS Pharmaceutics (NASDAQ: NCEL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Profitability This table compares USANA Health

Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval
prnewswire.com
2025-12-16 07:20:00SALT LAKE CITY , Dec. 16, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is proud to announce that its top-rated Probiotic supplement has earned the distinguished ConsumerLab.com Seal of Approval. This respected third-party certification recognizes products that meet the highest standards for purity, potency, and scientific accuracy.
No data to display

Protein Pop Launches Protein Pop Plus at Costco Nationwide
prnewswire.com
2026-02-25 07:07:00The brand expands its Protein Pop line with a carbonated, clear protein beverage delivering 30 grams of protein per can SALT LAKE CITY, Feb. 25, 2026 /PRNewswire/ -- Rise Wellness announced the expansion of its Protein Pop offering with the launch of Protein Pop Plus, a new carbonated, ready‑to‑drink clear protein beverage now available at all 607 Costco locations across the United States. Protein Pop Plus builds on the success of the brand's original Protein Pop line, offering consumers a bold new way to enjoy high‑protein nutrition in a refreshing, carbonated format.

Joshua Foukas Sells 4,461 Shares of USANA Health Sciences (NYSE:USNA) Stock
defenseworld.net
2026-02-25 04:44:53USANA Health Sciences, Inc. (NYSE: USNA - Get Free Report) insider Joshua Foukas sold 4,461 shares of the business's stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $21.34, for a total transaction of $95,197.74. The transaction was disclosed in a filing with the Securities and

USNA or UTHR: Which Is the Better Value Stock Right Now?
zacks.com
2026-02-23 12:41:11Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors?

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-18 12:55:13USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
zacks.com
2026-02-17 18:25:28USANA Health Sciences (USNA) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.64 per share a year ago.

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook
businesswire.com
2026-02-17 16:15:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results Q4 2025 Q4 2024 FY 2025 FY 2024 Net sales $226.2 $213.6 $925.3 $854.5 Net (loss) earnings* $-1.8 $4.5 $10.8 $42.0 Diluted EPS $-0.10 $0.23 $0.58 $2.19 Adjusted diluted EPS(1) $0.60 $0.64 $1.93 $2.59 Adjusted EBITDA(2) $27.3 $25.5 $101.3 $110.3 USAN.

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
zacks.com
2026-02-10 11:00:59USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

USANA Exec. Chairman/CEO Kevin Guest on Self-Renewal Day: Break Comfort Zones for Strategic Growth with Six Steps
prnewswire.com
2026-02-02 07:05:00SALT LAKE CITY, Feb. 2, 2026 /PRNewswire/ -- As organizations face rapid market disruption and evolving leadership demands, Feb. 2 marks Self-Renewal Day, a pivotal time for business leaders to recalibrate strategies and personal development. "Growth does not happen by accident; it happens by choice," said Kevin Guest, Executive Chairman & CEO at USANA Health Sciences (NYSE: USNA).

The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
prnewswire.com
2026-01-19 12:10:00/PRNewswire/ -- The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes

Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS)
feeds.newsfilecorp.com
2026-01-14 16:41:00Dallas, Texas--(Newsfile Corp. - January 14, 2026) - Stonegate Capital Partners attended the 2026

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
businesswire.com
2026-01-12 06:15:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA's strategy, including the Company's initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 cons.

Kevin Guest Returns to USANA Health Sciences as CEO
businesswire.com
2026-01-08 09:00:00SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and wi.

USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset
prnewswire.com
2026-01-05 07:13:00SALT LAKE CITY, Jan. 5, 2026 /PRNewswire/ -- As leaders everywhere set sights on the new year, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA), is encouraging professionals to embrace a growth mindset as the key to lasting achievement and fulfillment. "Success is about the experiences you have, the relationships you build, and the lessons you apply," said Guest, who is also the author of the bestseller, All the Right Reasons: 12 Principles for Living a Life in Harmony.

USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families
prnewswire.com
2025-12-23 06:52:00More than 5,100 food bags delivered to help support children during winter break SALT LAKE CITY , Dec. 23, 2025 /PRNewswire/ -- The holiday season is meant to be a time of celebration, yet for many children who depend on school meals, extended breaks can bring uncertainty. To help bridge that gap, the USANA Foundation - through its Utah-focused Kids Eat program - once again mobilized its annual holiday food pack initiative to help ensure families across Utah had access to nutritious meals while school was out of session.

Analyzing NLS Pharmaceutics (NASDAQ:NCEL) & USANA Health Sciences (NYSE:USNA)
defenseworld.net
2025-12-19 02:00:48USANA Health Sciences (NYSE: USNA - Get Free Report) and NLS Pharmaceutics (NASDAQ: NCEL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Profitability This table compares USANA Health

Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval
prnewswire.com
2025-12-16 07:20:00SALT LAKE CITY , Dec. 16, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is proud to announce that its top-rated Probiotic supplement has earned the distinguished ConsumerLab.com Seal of Approval. This respected third-party certification recognizes products that meet the highest standards for purity, potency, and scientific accuracy.










